Topical application of TNF-blockers;Topische Anwendung von TNF-Blockern

Deutsche Medizinische Wochenschrift

Volumn 138, Issue 8, 2013, Pages 381-385

  Teich, N ^a  

^a Leipzig und Schkeuditz ^*  (Germany)

Author keywords

Adalimumab; ankylosing spondylitis; Crohn's disease; Etanercept; Infliximab; osteoarthritis; rheumatoid arthritis; sciatica; uveitis

Indexed keywords

TUMOR NECROSIS FACTOR INHIBITOR;

ARTICLE; INFLAMMATION;

ADMINISTRATION, TOPICAL; ADULT; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CROHN DISEASE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INJECTIONS, INTRA-ARTICULAR; INJECTIONS, INTRALESIONAL; OSTEOARTHRITIS; PROSPECTIVE STUDIES; SCIATICA; SPONDYLITIS, ANKYLOSING; TUMOR NECROSIS FACTOR-ALPHA; UVEITIS;

EID: 84873518639     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-0032-1332919     Document Type: Article

References (50)

1. Alessandroni L., Kohn A., Cosintino R. et al. Local injection of infliximab in severe fistulating perianal Crohn's disease: an open uncontrolled study. Tech Coloproctol: 2011; 15 407 12
2. Alstergren P., Larsson P. T., Kopp S. Successful treatment with multiple intra-articular injections of infliximab in a patient with psoriatic arthritis. Scand J Rheumatol: 2008; 37 155 157 (Pubitemid 351536079)
3. Arias L., Caminal J. M., Badia M. B. et al. Intravitreal infliximab in patients with macular degeneration who are nonresponders to antivascular endothelial growth factor therapy. Retina: 2010; 30 1601 1608
4. Asteria C. R., Ficari F., Bagnoli S. et al. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study. Scand J Gastroenterol: 2006; 41 1064 1072 (Pubitemid 44385064)
5. Barde C., Laffitte E., Campanelli A. et al. Intralesional infliximab in noninfectious cutaneous granulomas: three cases of necrobiosis lipoidica. Dermatology: 2011; 222 212 216
6. Biancone L., Cretella M., Tosti C. et al. Local injection of infliximab in the postoperative recurrence of Crohn's disease. Gastrointest Endosc: 2006; 63 486 492 (Pubitemid 43261480)
7. Bliddal H., Terslev L., Qvistgaard E. et al. Safety of intra-articular injection of etanercept in small-joint arthritis: an uncontrolled, pilot-study with independent imaging assessment. Joint Bone Spine: 2006; 73 714 717 (Pubitemid 44918421)
8. Boesen M., Boesen L., Jensen K. E. et al. Clinical outcome and imaging changes after intraarticular (IA) application of etanercept or methylprednisolone in rheumatoid arthritis: magnetic resonance imaging and ultrasound-Doppler show no effect of IA injections in the wrist after 4 weeks. J Rheumatol: 2008; 35 584 591 (Pubitemid 351506353)
9. Bokarewa M., Tarkowski A. Local infusion of infliximab for the treatment of acute joint inflammation. Ann Rheum Dis: 2003; 62 783 784 (Pubitemid 36886419)
10. Cohen S. P., Wenzell D., Hurley R. W. et al. A double-blind, placebo-controlled, dose-response pilot study evaluating intradiscal etanercept in patients with chronic discogenic low back pain or lumbosacral radiculopathy. Anesthesiology: 2007; 107 99 105 (Pubitemid 46987825)
11. Cohen S. P., White R. L., Kurihara C. et al. Epidural steroids, etanercept, or saline in subacute sciatica: a multicenter, randomized trial. Ann Intern Med: 2012; 156 551 559
12. Conti F., Ceccarelli F., Priori R. et al. Intra-articular infliximab in patients with rheumatoid arthritis and psoriatic arthritis with monoarthritis resistant to local glucocorticoids. Clinical efficacy extended to patients on systemic anti-tumour necrosis factor alpha. Ann Rheum Dis: 2008; 67 1787 1790
13. Conti F., Malviya G., Ceccarelli F. et al. Role of scintigraphy with (99m)Tc-infliximab in predicting the response of intraarticular infliximab treatment in patients with refractory monoarthritis. Eur J Nucl Med Mol Imaging: 2012; 39 1339 1347
14. Cui Y., Xiao Z., Shuxia W. et al. Computed tomography guided intra-articular injection of etanercept in the sacroiliac joint is an effective mode of treatment of ankylosing spondylitis. Scand J Rheumatol: 2010; 39 229 232
15. Deleuran B. W., Chu C. Q., Field M. et al. Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis. Implications for local actions of tumor necrosis factor alpha. Arthritis Rheum: 1992; 35 1170 1178
16. Farvardin M., Afarid M., Mehryar M. et al. Intravitreal infliximab for the treatment of sight-threatening chronic noninfectious uveitis. Retina: 2010; 30 1530 1535
17. Fiocco U., Sfriso P., Oliviero F. et al. Synovial effusion and synovial fluid biomarkers in psoriatic arthritis to assess intraarticular tumor necrosis factor-α blockade in the knee joint. Arthritis Res Ther: 2010; 12 R148
18. Fioravanti A., Fabbroni M., Cerase A. et al. Treatment of erosive osteoarthritis of the hands by intra-articular infliximab injections: a pilot study. Rheumatol Int: 2009; 29 961 965
19. Fries W., Giofré M. R., Catanoso M. et al. Treatment of acute uveitis associated with Crohn's disease and sacroileitis with infliximab. Am J Gastroenterol: 2002; 97 499 500 (Pubitemid 34160796)
20. Giganti M., Beer P. M., Lemanski N. et al. Adverse events after intravitreal infliximab (Remicade). Retina: 2010; 30 71 80
21. Glaeske G., Schicketanz C. BARMER GEK Arzneimittelreport 2012. Asgard Verlagsservice GmbH: 2012
22. Hanauer S. B., Feagan B. G., Lichtenstein G. R. et al. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet: 2002; 359 1541 1549 (Pubitemid 34621118)
23. Haroon M., O'Gradaigh D. Efficacy and safety of combining intra-articular methylprednisolone and anti-TNF agent to achieve prolonged remission in patients with recurrent inflammatory monoarthritis. Joint Bone Spine: 2010; 77 232 234
24. Hehlgans T., Pfeffer K. The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games. Immunology: 2005; 115 1 20 (Pubitemid 40598088)
25. Karppinen J., Korhonen T., Malmivaara A. et al. Tumor necrosis factor-alpha monoclonal antibody, infliximab, used to manage severe sciatica. Spine: 2003; 28 750 753 (Pubitemid 36459288)
26. Korhonen T., Karppinen J., Malmivaara A. et al. Efficacy of infliximab for disc herniation-induced sciatica: one-year follow-up. Spine 2004 29 2115 2119
27. Korhonen T., Karppinen J., Paimela L. et al. The treatment of disc-herniation-induced sciatica with infliximab: one-year follow-up results of FIRST II, a randomized controlled trial. Spine: 2006; 31 2759 2766 (Pubitemid 44772773)
28. Lorenzo-Zúñiga V., Boix J., Mañosa M. et al. Local injection of infliximab in symptomatic isolated mucosal lesions: A novel scenario for endoscopic therapy? Inflamm Bowel Dis: 2012; in press
29. Markomichelakis N., Delicha E., Masselos S. et al. Intravitreal Infliximab for Sight-Threatening Relapsing Uveitis in Behçet Disease: A Pilot Study in 15 Patients. Am J Ophthalmol: 2012; 154 534 541
30. Martel J. N., Esterberg E., Nagpal A. et al. Infliximab and adalimumab for uveitis. Ocul Immunol Inflamm: 2012; 20 18 26
31. Mirshahi A., Hoehn R., Lorenz K. et al. Anti-tumor necrosis factor alpha for retinal diseases: current knowledge and future concepts. J Ophthalmic Vis Res: 2012; 7 39 44
32. Nikas S. N., Temekonidis T. I., Zikou A. K. et al. Treatment of resistant rheumatoid arthritis by intraarticular infliximab injections: a pilot study. Ann Rheum Dis: 2004; 63 102 103 (Pubitemid 38064614)
33. Ohtori S., Miyagi M., Eguchi Y. et al. Epidural administration of spinal nerves with the tumor necrosis factor-alpha inhibitor, etanercept, compared with dexamethasone for treatment of sciatica in patients with lumbar spinal stenosis: a prospective randomized study. Spine: 2012; 37 439 444
34. Okoro T., Tafazal S. I., Longworth S. et al. Tumor necrosis alpha-blocking agent (etanercept): a triple blind randomized controlled trial of its use in treatment of sciatica. J Spinal Disord Tech: 2010; 23 74 77
35. Olsen N. J., Stein C. M. New drugs for rheumatoid arthritis. N Engl J Med: 2004; 350 2167 2179
36. O'Shea F. D., Haroon N., Salonen D. C. et al. Clinical and radiographic response to a local infliximab injection in a patient with chronic sacroiliitis. Nat Clin Pract Rheumatol: 2009; 5 171 173
37. Poggioli G., Laureti S., Pierangeli F. et al. Local injection of adalimumab for perianal Crohn's disease: better than infliximab? Inflamm Bowel Dis: 2010; 16 1631
38. Poggioli G., Laureti S., Pierangeli F. et al. Local injection of Infliximab for the treatment of perianal Crohn's disease. Dis Colon Rectum: 2005; 48 768 774 (Pubitemid 40880725)
39. Pulido J. S., Pulido J. E., Michet C. J. et al. More questions than answers: a call for a moratorium on the use of intravitreal infliximab outside of a well-designed trial. Retina: 2010; 30 1 5
40. Schatteman L., Gyselbrecht L., De Clercq L. et al. Treatment of refractory inflammatory monoarthritis in ankylosing spondylitis byintraarticular injection of infliximab. J Rheumatol: 2006; 33 82 85 (Pubitemid 43054285)
41. Scott D. L., Kingsley G. H. Tumour necrosis factor inhibitors for rheumatoid arthritis. N Engl J Med: 2006; 355 704 712
42. Sfikakis P. P., Theodossiadis P. G., Katsiari C. G. et al. Effect of infliximab on sight-threatening panuveitis in Behçet's disease. Lancet: 2001; 358 295 296 (Pubitemid 32738970)
43. Shi J. Q., Wang B. R., Jiang W. W. et al. Cognitive improvement with intrathecal administration of infliximab in a woman with Alzheimer's disease. J Am Geriatr Soc: 2011; 59 1142 1144
44. Streit M., Beleznay Z., Braathen L. R. Topical application of the tumour necrosis factor-alpha antibody infliximab improves healing of chronic wounds. Int Wound J: 2006; 3 171 179
45. Swaminath A., Lichtiger S. Dilation of colonic strictures by intralesional injection of Infliximab in patients with Crohn's colitis. Inflamm Bowel Dis: 2008; 14 213 216 (Pubitemid 351288042)
46. Targan S. R., Hanauer S. B., van Deventer S. J. et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med: 1997; 337 1029 1035
47. Tonelli F., Giudici F., Asteria C. R. Effectiveness and safety of local adalimumab injection in patients with fistulizing perianal Crohn's disease: a pilot study. Dis Colon Rectum: 2012; 55 870 875
48. van der Bijl A. E., Teng Y. K., van Oosterhout M. et al. Efficacy of intraarticular infliximab in patients with chronic or recurrent gonarthritis: a clinical randomized trial. Arthritis Rheum: 2009; 61 974 978
49. Wallace H. J., Stacey M. C. Levels of tumor necrosis factor-alpha (TNF-alpha) and soluble TNF receptors in chronic venous leg ulcers-correlations to healing status. J Invest Dermatol: 1998; 110 292 296 (Pubitemid 28144608)
50. Wu L., Hernandez-Bogantes E., Roca J. A. et al. Intravitreal tumor necrosis factor inhibitors in the treatment of refractory diabetic macular edema: a pilot study from the Pan-American Collaborative Retina Study Group. Retina: 2011; 31 298 303